| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $88.6M | +6.4% | +17.7% |
| Cost of Revenue | $23.1M | +1.1% | +23.1% |
| Gross Profit | $65.5M | +8.3% | +16.0% |
| R&D Expense | $26.6M | +10.5% | +39.8% |
| SG&A Expense | $16.2M | -1.7% | -2.2% |
| Pre-tax Income | -$23.1M | +4.4% | -43.1% |
| Income Tax | $926K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $82.2M | -31.3% | -74.1% |
| Short-term Investments | $107.0M | +21.0% | +4186.2% |
| Accounts Receivable | $34.8M | -5.2% | +18.6% |
| Current Assets | $265.8M | -7.3% | -31.5% |
| Total Assets | $438.1M | -4.0% | -1.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.0M | — | — |
| Capital Expenditures | $1.4M | — | — |
| Investing Cash Flow | -$66.8M | — | — |
| Financing Cash Flow | -$39.6M | — | — |
| Free Cash Flow | $15.6M | — | — |
| +67.1% |
| +24.8% |
| Net Income | -$24.0M | +2.8% | -42.3% |
| EPS (Basic) | -$0.18 | +5.3% | -28.6% |
| EPS (Diluted) | -$0.18 | +5.3% | -28.6% |
| $170.8M |
| -0.4% |
| +12.1% |
| Total Liabilities | $175.9M | -0.7% | +13.0% |
| Stockholders' Equity | $262.2M | -6.2% | -9.6% |